Iain Wilkie
Stock Analyst at Morgans
(0.10)
# 4,811
Out of 5,119 analysts
164
Total ratings
29.1%
Success rate
-14.8%
Average return
Main Sectors:
Stocks Rated by Iain Wilkie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: NAN Nanosonics Limited | Reiterated: Buy | $4.00 → $3.50 | $2.89 | +21.11% | 8 | Nov 4, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Reiterated: Buy | $0.48 | $0.26 | +84.62% | 11 | Nov 2, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Reiterated: Buy | $5.06 | $2.45 | +106.53% | 2 | Nov 2, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Downgraded: Hold | $10.00 → $7.00 | $7.52 | -6.91% | 8 | Oct 21, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Downgraded: Hold | $0.12 → $0.08 | $0.04 | +116.22% | 11 | Oct 21, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $230.00 | $205.13 | +12.12% | 30 | Oct 19, 2026 | |
| ASX: NUZ Neurizon Therapeutics Limited | Reiterated: Buy | $0.20 | $0.06 | +212.50% | 12 | Oct 6, 2026 | |
| ASX: EIQ Echo IQ Limited | Reiterated: Buy | $1.85 → $1.10 | $0.50 | +120.00% | 4 | Sep 9, 2026 | |
| ASX: IME ImExHS Limited | Downgraded: Hold | $0.50 → $0.37 | $0.35 | +7.25% | 14 | Aug 31, 2026 | |
| ASX: SOM SomnoMed Limited | Reiterated: Buy | $0.75 → $0.76 | $0.29 | +162.07% | 21 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.43 | $0.10 | +338.78% | 7 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.58 → $0.24 | $0.00 | n/a | 8 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.22 → $0.29 | $0.03 | n/a | 4 | Sep 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.28 → $0.78 | $0.25 | n/a | 14 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.43 | $0.13 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.31 → $1.24 | $0.34 | n/a | 4 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.89 → $1.64 | $0.01 | n/a | 3 | Feb 16, 2022 |
Nanosonics Limited
Nov 4, 2026
Reiterated: Buy
Price Target: $4.00 → $3.50
Current: $2.89
Upside: +21.11%
Mach7 Technologies Limited
Nov 2, 2026
Reiterated: Buy
Price Target: $0.48
Current: $0.26
Upside: +84.62%
Vitrafy Life Sciences Limited
Nov 2, 2026
Reiterated: Buy
Price Target: $5.06
Current: $2.45
Upside: +106.53%
Clinuvel Pharmaceuticals Limited
Oct 21, 2026
Downgraded: Hold
Price Target: $10.00 → $7.00
Current: $7.52
Upside: -6.91%
Microba Life Sciences Limited
Oct 21, 2026
Downgraded: Hold
Price Target: $0.12 → $0.08
Current: $0.04
Upside: +116.22%
Pro Medicus Limited
Oct 19, 2026
Reiterated: Buy
Price Target: $230.00
Current: $205.13
Upside: +12.12%
Neurizon Therapeutics Limited
Oct 6, 2026
Reiterated: Buy
Price Target: $0.20
Current: $0.06
Upside: +212.50%
Echo IQ Limited
Sep 9, 2026
Reiterated: Buy
Price Target: $1.85 → $1.10
Current: $0.50
Upside: +120.00%
ImExHS Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $0.50 → $0.37
Current: $0.35
Upside: +7.25%
SomnoMed Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $0.75 → $0.76
Current: $0.29
Upside: +162.07%
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.10
Upside: +338.78%
Sep 2, 2024
Reiterated: Buy
Price Target: $0.58 → $0.24
Current: $0.00
Upside: n/a
Sep 1, 2022
Reiterated: Buy
Price Target: $0.22 → $0.29
Current: $0.03
Upside: n/a
Mar 9, 2022
Downgraded: Sell
Price Target: $1.28 → $0.78
Current: $0.25
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $1.43
Current: $0.13
Upside: n/a
Feb 24, 2022
Reiterated: Buy
Price Target: $1.31 → $1.24
Current: $0.34
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $1.89 → $1.64
Current: $0.01
Upside: n/a